Research advances in monitoring platelet function in patients with coronary artery disease
10.3760/cma.j.issn.1009-9158.2013.06.003
- VernacularTitle:冠心病患者血小板功能检测的意义及应用前景
- Author:
Ran TIAN
;
Yong ZENG
- Publication Type:Journal Article
- Keywords:
Coronary artery disease;
Platelet function tests;
Aspirin;
Ticlopidine;
Platelet glycoprotein GP Ⅱ b-Ⅲ a complex
- From:
Chinese Journal of Laboratory Medicine
2013;(6):489-493
- CountryChina
- Language:Chinese
-
Abstract:
Antiplatelet therapy and stent implantation have been the dominant treatment to reduce the mortality of patients with coronary artery disease.Recently,studies have showed that adverse cardiac events still occur in part of patients with coronary artery disease after the antiplatelet treatment with aspirin and/or clopidogrel.Thus,resistance to aspirin and clopidogrel has attracted increasing attention.It will be great benefit to these patients who were identified resistance and made tailoring antiplatelet therapy So far many platelet function tests has been used in clinical to monitor the reaction of the antiplatelet drugs for prevention and treatment of thrombosis in patients with coronary artery disease.These monitoring tests may be chosen based on different antiplatelet drugs including aspirin,clopidogrel and GP Ⅱ b/Ⅲ a antagonist.The results of antiplatelet drug resistance may be different due to different platelet function methods,thus the related clinical adverse events needs further verification.
